Brokerages Set BWX Technologies, Inc. (NYSE:BWXT) Target Price at $228.00

BWX Technologies, Inc. (NYSE:BWXT) has earned a consensus rating of “Moderate Buy” from the fifteen research firms that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have given a hold recommendation, eight have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $228.00.

A number of equities analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft raised shares of BWX Technologies from a “hold” rating to a “buy” rating and upped their price objective for the company from $205.00 to $255.00 in a research report on Friday, May 15th. Bank of America lifted their target price on BWX Technologies from $230.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday, March 25th. Weiss Ratings reiterated a “buy (b-)” rating on shares of BWX Technologies in a research note on Friday, May 22nd. Seaport Research Partners raised BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 price target for the company in a report on Monday, June 22nd. Finally, Zacks Research lowered BWX Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th.

BWX Technologies Trading Down 0.9%

BWXT opened at $169.61 on Tuesday. The firm’s 50 day moving average is $194.03 and its 200-day moving average is $202.97. BWX Technologies has a 52-week low of $136.18 and a 52-week high of $241.82. The company has a quick ratio of 2.33, a current ratio of 2.40 and a debt-to-equity ratio of 1.58. The firm has a market capitalization of $15.54 billion, a P/E ratio of 45.35, a P/E/G ratio of 2.92 and a beta of 0.74.

BWX Technologies (NYSE:BWXT) last announced its earnings results on Monday, May 4th. The technology company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $0.92 by $0.20. The business had revenue of $860.22 million during the quarter, compared to the consensus estimate of $837.47 million. BWX Technologies had a net margin of 10.20% and a return on equity of 31.33%. The business’s quarterly revenue was up 26.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.91 earnings per share. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. Analysts expect that BWX Technologies will post 4.6 EPS for the current fiscal year.

BWX Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 5th. Investors of record on Tuesday, May 19th were issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Tuesday, May 19th. BWX Technologies’s payout ratio is currently 28.88%.

Insider Buying and Selling

In other BWX Technologies news, CEO Rex D. Geveden sold 10,000 shares of BWX Technologies stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $204.81, for a total value of $2,048,100.00. Following the completion of the transaction, the chief executive officer owned 202,491 shares of the company’s stock, valued at $41,472,181.71. The trade was a 4.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $209.25, for a total transaction of $505,757.25. Following the transaction, the chief financial officer owned 6,884 shares of the company’s stock, valued at $1,440,477. This represents a 25.99% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On BWX Technologies

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. bought a new stake in BWX Technologies in the fourth quarter valued at $9,754,000. Massachusetts Financial Services Co. MA lifted its holdings in shares of BWX Technologies by 18.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 1,375,740 shares of the technology company’s stock valued at $237,783,000 after acquiring an additional 216,707 shares during the period. MGO One Seven LLC boosted its stake in shares of BWX Technologies by 354.7% in the 4th quarter. MGO One Seven LLC now owns 17,695 shares of the technology company’s stock valued at $3,058,000 after purchasing an additional 13,803 shares in the last quarter. Granahan Investment Management LLC acquired a new stake in shares of BWX Technologies in the 3rd quarter valued at $1,941,000. Finally, Intech Investment Management LLC grew its holdings in shares of BWX Technologies by 22.7% in the 4th quarter. Intech Investment Management LLC now owns 32,668 shares of the technology company’s stock worth $5,646,000 after purchasing an additional 6,053 shares during the last quarter. Institutional investors own 94.39% of the company’s stock.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non?defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.